Content development for corporate materials, annual reports and employee communications.
Media strategy to build relationships and ensure key messages are disseminated and appreciated by various target audiences.
Multichannel, targeted communications to key audiences to support client sales and marketing efforts.
Client guidance to communicate more effectively with investors and analysts.
Sometimes medical advances are relatively straight forward. Moximed’s KineSpring works like a shock absorber in the knee to treat osteoarthritis pain. Halsin launched KineSpring in several EU countries targeting both the medical community and potential patients.
There is much for patients to celebrate when a life saving or life changing treatment becomes available. Perhaps even more significant is when a completely new paradigm is introduced. uniQure’s Glybera became the first gene therapy approved in Europe. Halsin provided communications throughout the approval process.
Clinical Trial Recruitment
A cure for Parkinson’s disease is the goal. To get there, drugs need to be developed and clinical studies conducted. The Michael J Fox Foundation came to Halsin to coordinate the European launch of Fox Trial Finder, an online tool to match volunteers to clinical studies.
A consistent, two-way communication with investors and analysts is an essential element for public companies to be successful. Halsin organizes regular events with the investor community for QIAGEN to ensure a productive dialogue continues.
Halsin Partners provides communication solutions for the unique business challenges faced by the life science industry – from start up biotech to multi-billion market cap companies.
Translate complex scientific concepts to various target audiences
1st German biotech IPO
1st Gene therapy approval
1st Dual US/EU listing
1st RNAi merger
US and EU feet on the ground with local insight and knowledge of “ways of doing things”
Our client service model centers around providing the best team for each project. Whether it’s the launch of a medical device in five European countries or an event at a US scientific conference, we have the right team to ensure success. Our team members are senior consultants and experts in their fields. Each in-country consultant provides the local knowledge on the mood of the industry, the insights and particularities of the media and a sense of “how things work” on the ground.
Holly Teichholtz, Vice President, Communications and Content Strategies, The Michael J. Fox Foundation for Parkinson’s Research
Georgina Langdale, Marketing & Communications Manager, New Zealand Trade & Enterprise
Charl van Zyl, Chief Executive Officer, JADO Technologies GmbH
Justine E. Koenigsberg Senior Director, Corporate Communications and Investor Relations, Concert Pharmaceuticals, Inc.
If you are interested in finding out more about the communications services we offer, contact us on firstname.lastname@example.org or call us: +44 20 7318 2960
96 Kensington High Street
W8 4SG, UK